-
Identification of Lauric Acid as a Potent Sodium Channel NaV1.5 Blocker from Compound Chinese Medicine Wenxin Keli
09 Jan 2025 07:15 GMT
… sodium channel blockers like propafenone and flecainide, the … Fraction Library
WXKL (Buchang Pharmaceutical Co., Ltd, Lot No … of complementary and alternative medical treatment of arrhythmias. Am J … randomized controlled trials on Wenxin keli. Drug Des Devel …
-
Sigachi Industries Ltd arm receives CEP from EDQM for Propafenone Hydrochloride
01 Dec 2024 16:08 GMT
… involved.
- Propafenone Hydrochlride, widely used in the treatment of cardiac arrhythmias … diseases, growing adoption of generic medications, and rising healthcare expenditure … of providing reliable and sustainable pharmaceutical solutions on a global scale …
-
Sigachi Industries targets European market with Propafenone HCl CEP filing
29 Nov 2024 07:21 GMT
… significant market opportunity. The global Propafenone Hydrochloride market is currently valued … , and innovation in the active pharmaceutical ingredient (API) sector. The … and increasing adoption of generic medications, positioning Trimax Biosciences to …
-
Racial and Ethnic Differences in Initiation and Discontinuation of Antiarrhythmic Medications in Management of Atrial Fibrillation
27 Mar 2024 10:58 GMT
… dofetilide, dronedarone, flecainide, propafenone, sotalol, and disopyramide) …
Abbreviations: AAD, antiarrhythmic drug; AF, atrial fibrillation; … treatment patterns following initiation of antiarrhythmic medications. … of the CABANA trial, patients identified …
-
A dual-targeted drug inhibits cardiac ryanodine receptor Ca2+ leak but activates SERCA2a Ca2+ uptake
27 Nov 2023 17:06 GMT
… RyR channel pore-blocking drug approved for treatment of malignant hyperthermia, exhibited … , 2019). Interestingly, both flecainidine and propafenone, but not lidocaine, have been … Murayama (Juntendo University School of Medicine, Tokyo) and cultured in black …
-
Pfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases
05 Oct 2023 20:36 GMT
… clinical trials where ABRYSVO … treatment in reducing hospitalization and death, and whether the risk of potential drug-drug … dronedarone, flecainide, propafenone, quinidine
Anti-gout … doctor about the infant's medical status when deciding to get vaccinated …
-
Drug-Drug Interactions in Doxorubicin-Cyclophosphamide Regimen
06 Sep 2023 15:09 GMT
… medications to manage chronic diseases. However, the prevalence and severity of drug-drug … 47;or require medical intervention to minimize … five or more medications. The patients’ regimens … propafenone. For the other X-labeled Lexicomp potential DDIs, Drugs …
-
Pfizer’s PAXLOVID™ Receives FDA Approval for Adult Patients at High Risk of Progression to Severe COVID-19
25 May 2023 15:24 GMT
… Drug Administration (FDA) approved PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets) for the treatment … , dronedarone, flecainide, propafenone, quinidine
Anti-gout … including innovative medicines and vaccines. Every … for clinical trials, regulatory …
-
For Healthcare Professionals | FDA’s Examples of Drugs that Interact with CYP Enzymes and Transporter Systems
06 May 2023 14:57 GMT
abiraterone
2D6 moderate inhibitor
acyclovir
1A2 weak inhibitor
adefovir1
OAT1 substrate
alfentanil
3A4 sensitive substrate
allopurinol
1A2 weak inhibitor
…
-
Race and Ethnic and Sex Differences in Rhythm Control Treatment of Incident Atrial Fibrillation
29 May 2023 05:29 GMT
… from a multi-center trial, the Early Treatment of Atrial Fibrillation for … , Propafenone, Ibutilide, Sotalol, Dronedarone, Quinidine, and Disopyramide according to the National Drug … the differential use of medical services for treatment of AF by race …